Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment

The optimum retreatment strategy for chronic hepatitis C virus (HCV) patients who failed directly-acting antiviral agents (DAA)-based therapy is unknown. We herein report the outcomes of an HCV genotype (GT) 2a-infected patient with virologic failure following treatment with sofosbuvir plus ribaviri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Toru, Imai, Michitaka, Owaki, Takashi, Sato, Hiroki, Nozawa, Yujiro, Sano, Tomoe, Iwanaga, Akito, Seki, Keiichi, Honma, Terasu, Yoshida, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207807/
https://www.ncbi.nlm.nih.gov/pubmed/29780129
http://dx.doi.org/10.2169/internalmedicine.0621-17
_version_ 1783366589397073920
author Ishikawa, Toru
Imai, Michitaka
Owaki, Takashi
Sato, Hiroki
Nozawa, Yujiro
Sano, Tomoe
Iwanaga, Akito
Seki, Keiichi
Honma, Terasu
Yoshida, Toshiaki
author_facet Ishikawa, Toru
Imai, Michitaka
Owaki, Takashi
Sato, Hiroki
Nozawa, Yujiro
Sano, Tomoe
Iwanaga, Akito
Seki, Keiichi
Honma, Terasu
Yoshida, Toshiaki
author_sort Ishikawa, Toru
collection PubMed
description The optimum retreatment strategy for chronic hepatitis C virus (HCV) patients who failed directly-acting antiviral agents (DAA)-based therapy is unknown. We herein report the outcomes of an HCV genotype (GT) 2a-infected patient with virologic failure following treatment with sofosbuvir plus ribavirin (SOF+RBV) who was successfully retreated with ombitasvir/paritaprevir/ritonavir plus ribavirin (OBV/PTV/r+RBV).
format Online
Article
Text
id pubmed-6207807
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-62078072018-10-31 Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment Ishikawa, Toru Imai, Michitaka Owaki, Takashi Sato, Hiroki Nozawa, Yujiro Sano, Tomoe Iwanaga, Akito Seki, Keiichi Honma, Terasu Yoshida, Toshiaki Intern Med Case Report The optimum retreatment strategy for chronic hepatitis C virus (HCV) patients who failed directly-acting antiviral agents (DAA)-based therapy is unknown. We herein report the outcomes of an HCV genotype (GT) 2a-infected patient with virologic failure following treatment with sofosbuvir plus ribavirin (SOF+RBV) who was successfully retreated with ombitasvir/paritaprevir/ritonavir plus ribavirin (OBV/PTV/r+RBV). The Japanese Society of Internal Medicine 2018-05-18 2018-10-01 /pmc/articles/PMC6207807/ /pubmed/29780129 http://dx.doi.org/10.2169/internalmedicine.0621-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ishikawa, Toru
Imai, Michitaka
Owaki, Takashi
Sato, Hiroki
Nozawa, Yujiro
Sano, Tomoe
Iwanaga, Akito
Seki, Keiichi
Honma, Terasu
Yoshida, Toshiaki
Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment
title Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment
title_full Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment
title_fullStr Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment
title_full_unstemmed Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment
title_short Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment
title_sort successful ombitasvir/paritaprevir/ritonavir plus ribavirin retreatment for a chronic hepatitis c genotype 2a patient who relapsed after sofosbuvir plus ribavirin treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207807/
https://www.ncbi.nlm.nih.gov/pubmed/29780129
http://dx.doi.org/10.2169/internalmedicine.0621-17
work_keys_str_mv AT ishikawatoru successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT imaimichitaka successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT owakitakashi successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT satohiroki successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT nozawayujiro successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT sanotomoe successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT iwanagaakito successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT sekikeiichi successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT honmaterasu successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment
AT yoshidatoshiaki successfulombitasvirparitaprevirritonavirplusribavirinretreatmentforachronichepatitiscgenotype2apatientwhorelapsedaftersofosbuvirplusribavirintreatment

Ejemplares similares